Annuaire des Santé catégorie Maladies  

AREVA Med, an AREVA subsidiary, develops innovative production methods for the lead-212 isotope (Pb212). This rare isotope offers new opportunities to combat certain forms of cancer.

AREVA MED, 212Pb, Pb212, 212Pb RIT, RIT Pb 212, Radio-immunotherapy, alpha RIT, Radioimmunotherapy, RIT, RIT alpha, RIT 212Pb, alpha-radio-immunotherapy, Lead 212

Navigation Content Search Version FrançaiseEnglish versionGerman version Search Log in Register Open Alpha Ventus wind turbines in the North Sea "AREVA at a glance" brochure 2007 figures: Economic, social, societal and environmental data 2006 figures: Economic, social, societal and environmental data "2009 figures" economic, social, societal and environmental data 2009 Annual Results Tomorrow’s challenges mobilizing all talent Field Report: Discover pragmatic examples of customer benefits 24 hours in La Hague "The Path of Greatest Certainty" brochure Global offer Group Operations Finance News Careers Dialogue Home / Operations / Mining / Mines facilities around the world / AREVA MED Operations Mining Overview Activities in detail Mines facilities around the world A Lukisa AREVA Gabon AREVA MED About AREVA Med Fighting disease with lead-212 Production site The Advisory Committee AREVA Med press room World-class partners Contact us AREVA Mongol AREVA NC Niger AREVA Australia Pty Ltd AREVA Resources Senegal AREVA Resources Canada Inc AREVA Resources Centrafrique AREVA Resources Namibia AREVA Resources Southern Africa BESSINES COMINAK COMIN COMINOR COMUF KATCO Imouraren SA Jordan AREVA Resources JOUAC La Mancha Resources Inc. Le Bourneix The Ecarpière site Lodève PATHFINDER Mines Corporation (PMC) SOMAÃ�R Urangesellschaft mbH (UG) Records Front End Reactors and services Back End Renewable Energy AREVA Med AREVA Med is a pioneering AREVA subsidiary that develops new methods for producing medical-grade lead-212, a promising isotope for combating cancer and other diseases. Recognized by the Clinton Global Initiative in 2009, the company is committed to supporting the search for innovative new treatments. About AREVA Med Based in the United States, AREVA Med is helping advance nuclear medicine by producing lead-212 on an industrial scale. AREVA Med in detail Press releases More news 04/07/2011 The “public hearingâ€� period for the construction of AREVA Med’s new 212Pb production facility was successfully completed Read more 01/25/2011 AREVA Receives Landmark Authorization to Initiate Clinical Trials for Promising Anticancer Treatment Read more Fighting disease with lead-212 This rare isotope has the potential to make a major impact on how we treat cancer. Understanding lead-212’s role Building a lead-212 production site AREVA Med is launching the construction of an industrial-scale lead‑212 production unit at AREVA’s Bessines site in Limousin, France. Presentation of the site World-class partners AREVA Med works with leading research institutions worldwide on cutting-edge treatments for cancer. AREVA Med’s partners The AREVA Med Advisory Committee The AREVA Med Advisory Committee provides expert guidance and help with the ongoing development of the company in the field of radio-immunotherapy using AREVA Med 212Pb. The Advisory Committee video Play video Read the transcript (doc, 24Ko) TAO Project : innovation that’s helping medical research The goal of the TAO (AREVA Thorium for Oncology) project is to extract Lead 212, a rare isotope found in certain by-products of our processes. This radioisotope lies at the heart of promising nuclear medical research to develop new cancer treatments. AREVA Med press room The latest news, press releases, videos and more from AREVA Med. All news and resources Print Send Share 10/02/2011 - TF1 : It is an unexpected specialty. AREVA, the global leader in nuclear energy, has launched a battle against cancer.  See report 26/01/2011 – Le Figaro économie: AREVA innovates in nuclear medicine Read (in french pdf, 240Ko) Contacts Want to learn more about AREVA Med? Contact the team Dialogue Live dialogueAsk your questions to our experts Access dialogue AREVA locations throughout the world AREVA locations in detail Useful links Accessibility Site map Contact Legal notice Our website sections Discover: Sustainable development AREVA Fondation Dialogue Global offer: Global offer Nuclear Energy Renewable energy Our operations: Mining Front End Reactors & Services Back End Renewable Energies Carreers: Join us Our commitment Our professions Read our publications Reference document 2010 Download the document (pdf, 2,6Mo) "AREVA in 2009" Report on responsible growth Download the report (pdf, 3Mo) Copyright 2011 AREVA - All rights reserved         Energy is our future, don't waste it!